The DOI matches its Crossref record; 58 of the 60 references it cites were found in a registry or an index.
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
Open accessAbstract
Previous studies have shown that the translation level of in vitro transcribed messenger RNA (mRNA) is enhanced when its uridines are replaced with pseudouridines; however, the reason for this enhancement has not been identified. Here, we demonstrate that in vitro transcripts containing uridine activate RNA-dependent protein kinase (PKR), which then phosphorylates translation initiation factor 2-alpha (eIF-2α), and inhibits translation. In contrast, in vitro transcribed mRNAs containing pseudouridine activate PKR to a lesser degree, and translation of pseudouridine-containing mRNAs is not repressed. RNA pull-down assays demonstrate that mRNA containing uridine is bound by PKR more efficiently than mRNA with pseudouridine. Finally, the role of PKR is validated by showing that pseudouridine- and uridine-containing RNAs were translated equally in PKR knockout cells. These results indicate that the enhanced translation of mRNAs containing pseudouridine, compared to those containing uridine, is mediated by decreased activation of PKR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Substitution of chemically modified nucleotides in messenger ribonucleic acid (mRNA) enhances stability and transfection capability, and decreases immunogenicity1–3”
From Complete substitution with modified nucleotides in self-amplifying RNA suppresses the interferon response and increases potency (2025) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Native RNA activates pattern recognition receptors such as toll-like receptors and triggers type I interferon (IFN) production, resulting in translational shutoff and systemic inflammation3.”
From Complete substitution with modified nucleotides in self-amplifying RNA suppresses the interferon response and increases potency (2025) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This can be circumvented by the incorporation of naturally occurring nucleosides and by applying stringent purification to remove double-stranded RNA contaminants (19–21).”
From mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model (2022) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Transferring this concept to in vitro transcribed mRNA, for instance, pseudouridine-containing mRNAs reduced activation of known RNA sensors substantially.”
From Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals (2015) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The two uridine analogs pseudouridine (Ψ) or 1-methyl-pseudouridine (m1Ψ) are widely used for mRNA therapeutics because they can increase mRNA stability and help modulate the host immune response31,32.”
From Human 5′ UTR design and variant effect prediction from a massively parallel translation assay (2019) · cites this paper as [32]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“Although pseudouridine is primarily found in tRNA, rRNA, and small nuclear RNAs, pseudouridine-containing mRNAs were still translated and produced even more protein compared to unmodified mRNA.”
From Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals (2015) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, nucleoside modifications are well known to limit or even inhibit RNA sensor engagement.20,21,22”
From Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals (2015) · cites this paper as [22]
In the citing paper
“Nucleoside-modified mRNA can reduce the activation of TLRs, retinoic acid-inducible gene I (RIG-I), protein kinase R (PKR), and 2′-5′-oligoadenylate synthetase (OAS). Additionally, nucleoside modification increases translation activity and resistance against RNase L-mediated degradation.54,81,173–176”
From Advances in COVID-19 mRNA vaccine development (2022) · cites this paper as [174]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728
Self-citation5'-Triphosphate RNA Is the Ligand for RIG-I
Hornung, V., Ellegast, J., Kim, S., Brzózka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K.-K., Schlee, M., et al. (2006) · Science · doi:10.1126/science.1132505 · Cited by 2,474
Karikó, K., Muramatsu, H., Welsh, F. A., Ludwig, J., Kato, H., Akira, S., & Weissman, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.200 · Cited by 1,930
Self-citationActivation of the interferon system by short-interfering RNAs
Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H., & Williams, B. R. G. (2003) · Nature Cell Biology · doi:10.1038/ncb1038 · Cited by 1,401
AAV vector integration sites in mouse hepatocellular carcinoma
Donsante, A., Miller, D. G., Li, Y., Vogler, C., Brunt, E. M., Russell, D. W., & Sands, M. S. (2007) · Science · doi:10.1126/science.1142658 · Cited by 662
Pseudouridine in RNA: What, Where, How, and Why
Charette, M., & Gray, M. W. (2000) · IUBMB Life · doi:10.1080/152165400410182 · Cited by 600
Ryter, J. M., & Schultz, S. C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7505 · Cited by 479
The RNA Modification Database: 1999 update
Rozenski, J., Crain, P. F., & McCloskey, J. A. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.196 · Cited by 390
2′-O-methyl-modified RNAs Act as TLR7 Antagonists
Robbins, M., Judge, A. D., Liang, L. Y., McClintock, K., Yaworski, E., & MacLachlan, I. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300240 · Cited by 339
Genotoxicity of Retroviral Integration In Hematopoietic Cells
Nienhuis, A. W., Dunbar, C. E., & Sorrentino, B. P. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.001 · Cited by 301
Flagged first, then by citations
2 of the 60 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 684
Cracking the Code: Enhancing Molecular Tools for Progress in Nanobiotechnology
Avila, Y. I., Rebolledo, L. P., Skelly, E., Saito, R. D. F., Wei, H., Lilley, D. M. J., Stanley, R. E., Hou, Y., Yang, H., Sztuba-Solińska, J., et al. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c00432 · Cited by 9
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity
Amini, A., Klenerman, P., & Provine, N. M. (2024) · Current Opinion in Virology · doi:10.1016/j.coviro.2024.101412 · Cited by 8
Cantero, M. J., Bueloni, B., Llamazares, L. G., Fiore, E. J., Mauriz, L. L., Atorrasagasti, C., Mazzolini, G. D., Malvicini, M., Bayo, J., & García, M. G. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03806-0 · Cited by 8
mRNA Vaccination: An Outlook on Innate Sensing and Adaptive Immune Responses
Doost, J. S., Fazel, F., Boodhoo, N., & Sharif, S. (2024) · Viruses · doi:10.3390/v16091404 · Cited by 9
Non-vesicular extracellular RNA: A potential drug target to intervene cell-cell communication
Tomita, T. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108774 · Cited by 8
Developing Biomaterial‐Based mRNA Delivery System for Lung Disease Treatment
Gu, Q., Xue, H., Liu, Z., Rao, J., Zeng, L., Zhang, C., Lei, L., & Shi, L. (2025) · Advanced Science · doi:10.1002/advs.202505413 · Cited by 11
Szebeni, J., & Koller, Á. (2025) · Vaccines · doi:10.3390/vaccines13080855 · Cited by 11
Liu, J., Xia, Y., Tian, C., Chen, Z., Guo, W., Liu, Y., Wen, J. A., Xie, Z., Lin, J., Li, J., et al. (2025) · Journal of Virology · doi:10.1128/jvi.00978-25 · Cited by 8
Lü, T., Chen, A., Li, C., Li, K., Wang, S., Zhang, Y., Yang, B., Wang, J., Gong, Q., Li, A., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf963 · Cited by 8
Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective
Blakney, A. K., Top, K. A., Cowling, B. J., Larson, H. J., Shattock, R. J., & Sadarangani, M. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00512-x · Cited by 11
Pseudouridylation-mediated gene expression modulation
Chen, J. L., Leeder, W. ‐., Morais, P., Adachi, H., & Yu, Y. (2024) · Biochemical Journal · doi:10.1042/bcj20230096 · Cited by 9
Advancing in vivo reprogramming with synthetic biology
Islam, F., Lewis, M. R., Craig, J. D., Leyendecker, P. M., & Deans, T. L. (2024) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2024.103109 · Cited by 8
An mRNA-LNP-based Lassa virus vaccine induces protective immunity in mice
Hashizume, M., Takashima, A., & Iwasaki, M. (2024) · Journal of Virology · doi:10.1128/jvi.00578-24 · Cited by 8
Non‐m6A RNA modifications in haematological malignancies
Chen, M., Chen, Y., Wang, K., Deng, X., & Chen, J. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1666 · Cited by 8
Strategic deactivation of mRNA COVID‐19 vaccines: New applications for siRNA therapy and RIBOTACs
Hulscher, N., McCullough, P. A., & Marotta, D. E. (2024) · The Journal of Gene Medicine · doi:10.1002/jgm.3733 · Cited by 9
Forsdyke, D. R. (2024) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2024.111943 · Cited by 8
Liu, W., Alameh, M., Yang, J. F., Xu, J. R., Lin, P. J. C., Tam, Y. K., Weissman, D., & You, J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.08.475499 · Cited by 8
Self-citationEngineering programmable RNA synthetic circuits in mammalian cells
Cella, F., Martino, I. D., Piro, F. R., & Siciliano, V. (2021) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2021.100395 · Cited by 7
Sioud, M. (2023) · Scandinavian Journal of Immunology · doi:10.1111/sji.13282 · Cited by 8
Silas, D. S., Juneja, B., Kaur, K., Gari, M. N., You, Y., Moon, Y., Chen, Y., Arora, S., Hansen, J. K., Muthusamy, K., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16091227 · Cited by 7
Effective Synthesis of mRNA during In Vitro Transcription with Fewer Impurities Produced
He, W., Geng, Q., Ji, G., Li, J., Wang, D., He, Y.-C., Jin, Q., & Ye, J. (2024) · Molecules · doi:10.3390/molecules29194713 · Cited by 8
Metabolic Characteristics of Sclera in Lens-Induced Myopic Guinea Pigs
Lin, X., Zheng, C., Cong, J., Feng, Q., Yuan, J., Liu, S., Li, H., Feng, C., & Dai, J. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.13.51 · Cited by 7
Lin, C., Kuzmanović, A., Wang, N., Liao, L., Ernst, S., Penners, C., Jans, A., Hammoor, T., Stach, P. B., Peltzer, M., et al. (2025) · Advanced Science · doi:10.1002/advs.202409729 · Cited by 7
Quintana, V. M., Caillava, J., Byk, L. A., Mondotte, J. A., Battini, L., Tarte, P., Samsa, M. M., Filomatori, C. V., & Alvarez, D. E. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110487 · Cited by 7
Chemical Modifications in Nucleic Acid Therapeutics
Lennox, K. A., Young, R. C., & Behlke, M. A. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4742-4_3 · Cited by 8
Iwai, H., Kimura, Y., Honma, M., Nakamoto, K., Hashimoto, A., Motosawa, K., Atago, T., Asano, K., Hashiya, F., Abe, N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65788-8 · Cited by 8
RNA Aptamers and Epitranscriptomics: Charting Unexplored Territories in RNA Biology
Khorshid, M., & Ahi, E. P. (2026) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-026-00841-w · Cited by 7
Probst, J., Fotin‐Mleczek, M., Schlake, T., Theß, A., Kramps, T., & Kallen, K. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0439-2_11 · Cited by 7
mRNA as a Therapeutics: Understanding mRNA Vaccines
Oğuz, F., & Atmaca, H. (2021) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2022.028 · Cited by 8
Lipofection with Synthetic mRNA as a Simple Method for T-Cell Immunomonitoring
Jarzębska, N. T., Frei, J., Läuchli, S., French, L. E., Guenova, E., Gouttefangeas, C., Kündig, T. M., Mellett, M., & Pascolo, S. (2021) · Viruses · doi:10.3390/v13071232 · Cited by 7
Sterile activation of RNA-sensing pathways in autoimmunity
Li, J., Zhu, J., Yang, H., & Hou, F. (2024) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjae029 · Cited by 7
Overcoming antifungal resistance in Candida albicans via RNA interference: a therapeutic perspective
Mundhe, A. K., & Rajkumari, R. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1675921 · Cited by 7
Choi, H., Lee, S., Kim, H., Bae, S., Jo, S., Kim, J., Lee, Y., Ha, D., Oh, A., Yoon, S., et al. (2025) · Journal of Biological Engineering · doi:10.1186/s13036-025-00573-1 · Cited by 6
RNA modifications as a means of self-recognition and immune protection
Cao, Q., & Duan, Y. (2025) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2025.2591027 · Cited by 6
Beyond the Sequence: Chemical and Topological Design and Innovations in mRNA Therapeutics
Liu, D., Chen, H., Pan, A., & Wang, X. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00347 · Cited by 7
Immunological mechanisms of mRNA vaccines for infectious diseases
Locci, M., & Pardi, N. (2026) · Nature · doi:10.1038/s41586-026-10599-0 · Cited by 6
Alom, K. M., Asa, T. A., & Seo, Y. J. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00420 · Cited by 6
Xu, J., Yang, Z., Wang, R., He, F., Yan, R., Zhang, Y., Yu, L., Deng, W., & Nie, Y. (2022) · Communications Biology · doi:10.1038/s42003-022-04043-y · Cited by 6
Gamper, H., McCormick, C. A., Makhamreh, A. K., Wanunu, M., Rouhanifard, S. H., & Hou, Y. (2023) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2023.04.024 · Cited by 6
Sterner, E. A. (2023) · Science & Technology Libraries · doi:10.1080/0194262x.2023.2292047 · Cited by 6
Next-Generation Therapeutics: mRNA as a Novel Therapeutic Option for Single-Gene Disorders
Michel, T., Wendel, H.-P., & Krajewski, S. (2016) · InTech eBooks · doi:10.5772/62243 · Cited by 7
Michel, T., Link, A., Abraham, M.-K., Schlensak, C., Peter, K., Wendel, H.-P., Wang, X., & Krajewski, S. (2019) · Journal of Visualized Experiments · doi:10.3791/58444 · Cited by 7
Controlling Protein Expression by Delivery of RNA Therapeutics Using Lipid Nanoparticles
Lin, P. J. C., & Tam, Y. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814470-1.00009-5 · Cited by 6
SARS-CoV-2 mRNA vaccine is re-adenylated in vivo , enhancing antigen production and immune responsePreprint
Krawczyk, P. S., Gewartowska, O., Mazur, M., Orzeł, W., Matylla-Kulińska, K., Jeleń, S., Turowski, P., Śpiewla, T., Tarkowski, B., Tudek, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.01.518149 · Cited by 5
Iwai, H., Kimura, Y., Honma, M., Nakamoto, K., Motosawa, K., Atago, T., Asano, K., Hashiya, F., Abe, N., Kobayashi, K., et al. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-bwpx6 · Cited by 6
Precision mRNA Nanomedicine for Targeted Vascular Therapies in ARDS and AtherosclerosisPreprint
Zhou, Z., Zhu, J., Yeh, C., Meliton, A. Y., Wu, D., Huang, R., Shentu, T., Ray, A. G., Wiseman, D., Budina, E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.09.632179 · Cited by 6
Messenger RNA and Plasmid DNA Vaccines for the Treatment of Cancer
Moseman, J. E., Shim, D., Jeon, D., Rastogi, I., Schneider, K. M., & McNeel, D. G. (2025) · Vaccines · doi:10.3390/vaccines13090976 · Cited by 5
Terai, Y., Yada, E., Nakanishi, H., & Itaka, K. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101254 · Cited by 5
A combined pseudouridine biomanufacturing platform enabled by a streamlined designer pathway
Yu, L., Chen, R., Zhang, C., Wang, Z., Wang, Z., Zeng, X., Liang, H., He, Y., She, Y., Wang, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63906-0 · Cited by 5
Crystallographic insight into the binding modes of group 12 metal cations with N7-alkylated purines
Panda, S. J., Agrawalla, S. K., & Purohit, C. S. (2024) · CrystEngComm · doi:10.1039/d4ce00341a · Cited by 5
Unlocking Immunity: Innovative prostate cancer vaccine strategies
Gu, Q., Qi, A., Wang, N., Zhou, Z., & Zhou, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113137 · Cited by 7
A Brief Chronicle of Antibody Research and Technological Advances
Araki, K., & Maeda, R. (2024) · Antibodies · doi:10.3390/antib13040090 · Cited by 9
Oliveira, A. S. D., Versteeg, L., Briggs, N., Adhikari, R., Villar, M. J., Redd, J. R., Hotez, P. J., Bottazzi, M. E., & Pollet, J. B. K. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012809 · Cited by 6
A review of advances in in vitro RNA preparation by ssRNAP
Shen, Y., Yang, D.-Q., Liu, Y., Lao, J.-E., Liu, C., Gao, X., He, Y.-R., & Xia, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141002 · Cited by 5
Selection of UTRs in mRNA-Based Gene Therapy and Vaccines
Volkhin, I. A., Paremskaia, A. I., Dashian, M. A., Smeshnova, D. S., Pavlov, R. E., Mityaeva, O. N., Volchkov, P. Y., & Deviatkin, A. A. (2025) · Biochemistry (Moscow) · doi:10.1134/s0006297924604659 · Cited by 7
Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine
Dhanjal, D. S., Singh, R., Sharma, V., Nepovimová, E., Adam, V., Kuča, K., & Chopra, C. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230503144619 · Cited by 5
Influence of N1-Methylpseudouridine in Guide RNAs on CRISPR/Cas9 Activity
Prokhorova, D. V., Matveeva, A. M., Zakabunin, A., Ryabchenko, A., & Stepanov, G. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242317116 · Cited by 6
Prix Nobel de physiologie ou médecine 2023 : Katalin Karikó et Drew Weissman
Dieu‐Nosjean, M., & Teillaud, J. (2024) · médecine/sciences · doi:10.1051/medsci/2024002 · Cited by 5
Nanoimaging of SARS-CoV-2 viral invasion toward the nucleus and genome
Sajidah, E. S., Lim, K., Hazawa, M., & Wong, R. W.-C. (2024) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2024.102111 · Cited by 5
Shanmugasundaram, M., Senthilvelan, A., & Kore, A. R. (2018) · Tetrahedron Letters · doi:10.1016/j.tetlet.2018.12.001 · Cited by 5
Pseudouridine in RNA: Enzymatic Synthesis Mechanisms and Functional Roles in Molecular Biology
Khan, A. (2023) · International Journal of Environment Agriculture and Biotechnology · doi:10.22161/ijeab.86.25 · Cited by 5
A layperson encounter, on the “modified” RNA world
Pederson, T. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110706118 · Cited by 5
Synthesis of Long RNA with a Site-Specific Modification by Enzymatic Splint LigationPreprint
Gamper, H., McCormick, C. A., Tavakoli, S., Wanunu, M., Rouhanifard, S. H., & Hou, Y. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.17.508400 · Cited by 5
Buggert, M., & Höglund, P. (2023) · Scandinavian Journal of Immunology · doi:10.1111/sji.13340 · Cited by 5
Fifty years of Nucleic Acids Research
Sale, J. E., & Stoddard, B. L. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad1156 · Cited by 5
Cross-competition shapes CD8+ T cell hierarchies and differentiation after RNA vaccinationPreprint
McCarron, M. J., Hornburg, M., Wu, T. D., Tong, A.-J., Tähtinen, S., Darwish, M., Freund, E. C., Feng, Y., Eisel, D., Balança, C.-C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.26.684631 · Cited by 5
SEISMICgraph: a web-based tool for RNA structure data visualization
Wightman, F. F., Yang, G., Taillades, Y. J. M. D., L’Esperance-Kerckhoff, C., Grote, S. L., Allan, M. F., Herschlag, D., Rouskin, S., & Hagler, L. D. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf701 · Cited by 4
Engineering Anti-Tumor Immunity: An Immunological Framework for mRNA Cancer Vaccines
Roy, O., & Anderson, K. S. (2025) · Vaccines · doi:10.3390/vaccines13121222 · Cited by 5
Research progress of RNA pseudouridine modification in nervous system
Chen, H., & Zhao, S. (2024) · International Journal of Neuroscience · doi:10.1080/00207454.2024.2315483 · Cited by 4
Li, J., & Foged, C. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2409142 · Cited by 5
mRNA therapy: A new frontier in regenerative medicine
Xue, D., Zhang, Y., Shen, A., Tang, T., Liu, B., & Lv, L. (2025) · Interdisciplinary medicine · doi:10.1002/inmd.20240054 · Cited by 5
Exploring the Role of mRNA Methylation in Insect Biology and Resistance
Zhang, J., Lin, L., Huang, B., Liu, H., Li, H., & Wu, W. (2025) · Insects · doi:10.3390/insects16050463 · Cited by 4
Adjmi, M., Tse, I., & Zangi, L. (2025) · Cardiology Plus · doi:10.1097/cp9.0000000000000118 · Cited by 4
Ghayoumian, M., Shamsi, F., Madanchi, H., Ranjbar, M. M., Jalalirad, R., Sarrami‐Forooshani, R., & Mahdavi, M. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115315 · Cited by 4
Incorporating mRNA therapeutics into biological treatments of hematologic malignancies
Hunia, J., Tomasik, J., Czerwik, N., Pezeshki, P. S., & Nowis, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1680071 · Cited by 6
Zha, Y., Fan, L., Shen, T., Zhang, Y., & Ren, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-29758-w · Cited by 4
Navigating molecular therapies: The emerging role of mRNA in treating inherited metabolic diseases
Castro-Alpízar, J., Lenderink, M. J., Nieuwenhuis, E. E. S., Kooijmans, S. A. A., & Fuchs, S. A. (2025) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2025.109698 · Cited by 4
Feng, Z., Chu, L., Li, Q., Zhou, J., Wu, P., Zhang, X., Pan, Y., Zou, J., Chen, Q., Xu, Z., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68364-w · Cited by 4
Pan, Y., Li, X., Zhou, B., Zhuang, Y., Luo, L., Zhu, C., Xu, R., Jiang, Y., Dong, Y., Hao, Z., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c04991 · Cited by 4
Tributaries of the 2023 Nobel Prize in Physiology or Medicine, and lessons learned
Pederson, T. (2023) · RNA · doi:10.1261/rna.079874.123 · Cited by 5
Boulch, M. L., Jacquet, E., Nhiri, N., Shmulevitz, M., & Jais, P. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-55947-0 · Cited by 4
Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?
Harper, J. L., Betts, M. R., Lichterfeld, M. D., Müller-Trutwin, M. C., Margolis, D. M., Bar, K. J., Li, J. Z., McCune, J. M., Lewin, S. R., Kulpa, D. A., et al. (2024) · Pathogens and Immunity · doi:10.20411/pai.v8i2.665 · Cited by 6
Pallás, R. M. (2024) · Vacunas (English Edition) · doi:10.1016/j.vacune.2024.05.002 · Cited by 5
Bettinsoli, V., Melzi, G., Crea, A., Esposti, L. D., Iafisco, M., Catalucci, D., Ciana, P., & Corsini, E. (2025) · Life · doi:10.3390/life15010095 · Cited by 4
Gram‐Scale Chemical Synthesis of Base‐Modified Ribonucleoside‐5′‐O‐Triphosphates
Shanmugasundaram, M., Senthilvelan, A., & Kore, A. R. (2016) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/cpnc.20 · Cited by 4
RNA ImmunoGenic Assay: Simple method for detecting immunogenicity of in vitro transcribed mRNA
Haque, A. K. M. A., Weinmann, P., Biswas, S., Handgretinger, R., Mezger, M., Kormann, M., & Antony, J. S. (2020) · Advances in Cell and Gene Therapy · doi:10.1002/acg2.79 · Cited by 4
Molecular elements: novel approaches for molecular building
Wang, R., Wang, X., Xie, S., Zhang, Y., Ji, D., Zhang, X., Cui, C., Jiang, J., & Tan, W. (2023) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0024 · Cited by 4
Regulation of RNA Stability Through RNA Modification
Kawata, K., & Akimitsu, N. (2021) · RNA technologies · doi:10.1007/978-3-030-71612-7_8 · Cited by 4
Epitranscriptomics Markers Regulate the Infection by RNA Viruses
Stamatopoulou, V., & Zaravinos, A. (2021) · RNA technologies · doi:10.1007/978-3-030-71612-7_5 · Cited by 4
Modified h CFTR mRNA restores normal lung function in a mouse model of cystic fibrosisPreprint
Haque, A. A., Dewerth, A., Antony, J. S., Riethmüller, J., Latifi, N., Yasar, H., Weinmann, P., Pedemonte, N., Sondo, E., Laval, J., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/202853 · Cited by 4
Diensthuber, G., Pryszcz, L. P., Llovera, L., Lucas, M. C., Delgado-Tejedor, A., Cruciani, S., Roignant, J., Begik, O., & Novoa, E. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.28.568965 · Cited by 4
Selective RNA pseudouridinylation in situ by circular gRNAs in designer organellesPreprint
Schartel, L., Jann, C., Wierczeiko, A., Butto, T., Mündnich, S., Marchand, V., Motorin, Y., Helm, M., Gerber, S., & Lemke, E. A. (2024) · Research Square · doi:10.21203/rs.3.rs-4756705/v1 · Cited by 4
Mitigating Cellular Dysfunction by Addressing Contaminants in Synthetic circRNAPreprint
Zhang, Z., Li, W., Luo, D., Yuan, X., Yu, L., Wang, D., & Cao, Y. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.17.613157 · Cited by 4
A Historical Overview on mRNA Vaccine Development
Verbeke, R., Cheng, M. H. Y., & Cullis, P. R. (2024) · Wiley eBooks · doi:10.1002/9783527838394.ch1 · Cited by 5
Styles, T. M., Akhtar, A., Gu, C., Neumann, G., Muramatsu, H., McPartlan, J. S., Talukder, P., Gratz, D., Stokdyk, K., Turner, H. L., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102369 · Cited by 3
Self-citationAdvancements in breast cancer mRNA vaccines: Current development and future prospects
Zheng, W., Chen, W., Hutvágner, G., Rangel, L., & Deng, W. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189515 · Cited by 3
Heendeniya, S. N., Chen, S., Bhatti, S. H., Zahra, Q. U. A., Rahimizadeh, K., Poudel, B. H., Wilton, S. D., & Veedu, R. N. (2025) · Experimental Biology and Medicine · doi:10.3389/ebm.2025.10784 · Cited by 3
Dahm, G. C., Pieper, M., Schepers, H., & Rentmeister, A. (2026) · ChemMedChem · doi:10.1002/cmdc.202500826 · Cited by 6
Huang, X., Gao, X., An, Z., Yan, Y., Guo, X., Wang, Q., Zhao, C., Wang, X., & Fan, X. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.174782 · Cited by 3
Strategies to Improve the Stability and Translation of Therapeutic mRNAs
Gao, B., He, S., & Sun, Q. (2026) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-100724-084241 · Cited by 3
Metadata
- Authors
- Anderson, B. R., Muramatsu, H., Nallagatla, S. R., Bevilacqua, P. C., Sansing, L. H., Weissman, D., & Karikó, K.
- Affiliations
- Pennsylvania State University (US)
- Corresponding author
- Karikó, Katalin
- ORCID
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-05-10
- Volume
- 38
- Issue
- 17
- Pages
- 5884-5892
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC2943593
- OpenAlex
- W2156788486
- Cited by
- 682
- References
- 60
- Citations by year
- 2026: 67 · 2025: 99 · 2024: 143 · 2023: 90 · 2022: 77 · 2021: 52 · 2020: 22 · 2019: 22 · 2018: 26 · 2017: 17 · 2016: 21 · 2015: 13 · 2014: 6 · 2013: 12 · 2012: 8
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Cleveland Clinic
- Cleveland Clinic Foundation
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R42HL087688)
- National Institute of General Medical Sciences (T32GM007229, R01GM058709)
- National Institute of Allergy and Infectious Diseases (R01AI050484)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007748)
- National Institute of Dental and Craniofacial Research (R21DE019059)
- National Center for Research Resources (T32RR007063)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- pseudouridine, mRNA translation, PKR, RNA-dependent protein kinase, eIF2α phosphorylation, translation initiation, uridine, in vitro transcribed mRNA, RNA-protein interactions
- MeSH terms
- Animals, Cell Line, Cells, Cultured, Humans, Pseudouridine, RNA, Messenger, Protein Biosynthesis, eIF-2 Kinase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
